6 employees
Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases
2017
$11M
from 4 investors over 4 rounds
Genascence Corporation raised $5M on August 1, 2022
Investors: FAN Fund
Genascence Corporation raised $11M on January 7, 2022
Investors: Personnel Administrative Svcs, FAN Fund and Pacira Pharmaceuticals